购物车
- 全部删除
- 您的购物车当前为空
NLRP3-IN-2 (5-Chloro-N-(p-sulfamoylphenethyl)-o-anisamide) 是一种能够合成格列本脲的中间物,对心肌细胞中NLRP3炎症小体的形成具有抑制作用,在小鼠心肌缺血/再灌注后限制梗死面积,且对代谢无影响。
为众多的药物研发团队赋能,
让新药发现更简单!
NLRP3-IN-2 (5-Chloro-N-(p-sulfamoylphenethyl)-o-anisamide) 是一种能够合成格列本脲的中间物,对心肌细胞中NLRP3炎症小体的形成具有抑制作用,在小鼠心肌缺血/再灌注后限制梗死面积,且对代谢无影响。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 159 | 现货 | |
50 mg | ¥ 223 | 现货 | |
100 mg | ¥ 297 | 现货 | |
200 mg | ¥ 433 | 现货 | |
500 mg | ¥ 719 | 现货 | |
1 g | ¥ 1,060 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 150 | 现货 |
产品描述 | NLRP3-IN-2 (5-Chloro-N-(p-sulfamoylphenethyl)-o-anisamide), an intermediate capable of synthesizing glibenclamide, exerts an inhibitory effect on the formation of NLRP3 inflammatory vesicles in cardiomyocytes, limiting infarct size after myocardial ischemia/reperfusion in mice and has no effect on metabolism. |
别名 | 5-Chloro-N-(p-sulfamoylphenethyl)-o-anisamide, 4-[2-(5-氯-2-甲氧基苯甲酰氨基)乙基]苯磺酰胺, NLRP3 Inflammasome Inhibitor I |
分子量 | 368.84 |
分子式 | C16H17ClN2O4S |
CAS No. | 16673-34-0 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 55 mg/mL (149.12 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.